Microengineering methods for cell-based microarrays and high-throughput drug-screening applications.

Area of Science:

• Biomedical Engineering
• Drug Discovery
• Cell Biology

Background:

• Traditional drug screening is expensive, time-consuming, and relies heavily on animal models.
• Current in vitro methods like cell microarrays and microfluidics improve throughput but remain costly and lack in vivo relevance.
• There is a critical need for advanced 3D cell-based models that better replicate native tissue environments for drug screening.

Purpose of the Study:

• To review state-of-the-art microengineering approaches for developing 3D cell-based drug screening assays.
• To highlight the application of these advanced systems in high-throughput drug screening.
• To identify promising technologies for future drug discovery platforms.

Main Methods:

• Review of microengineering techniques for 3D cell culture and drug screening.
• Discussion of microfluidic systems integrated with cell-based arrays.
• Focus on bioprinting as a key technology for creating 3D cell constructs.

Main Results:

• Microfluidic and cell microarray systems enhance throughput but face cost barriers.
• 3D cell-based models are essential for mimicking in vivo conditions.
• Bioprinting demonstrates significant potential for creating versatile and controlled 3D cell constructs.

Conclusions:

• Bioprinting offers a promising microengineering approach for developing repeatable 3D cell-based drug screening constructs.
• These advanced 3D models have high temporal and spatial control, enhancing drug discovery efficiency.
• Microengineered 3D systems represent a significant advancement over traditional methods for therapeutic agent screening.